French drugmaker Valneva Vaccinates First Pediatric Trial Patient with “Single-Shot Chikungunya Vaccine”
by News Desk from Outbreak News Today on (#6HVR9)
Valneva SE announced this week that the first participant has been vaccinated in the Phase 2 clinical trial evaluating the safety and Immunogenicity in children of two different dose levels of Valneva's single-shot chikungunya vaccine. The Company reported positive pivotal Phase 3 data in adolescents two months ago confirming the immunogenicity and safety profile observed [...]
The post French drugmaker Valneva Vaccinates First Pediatric Trial Patient with Single-Shot Chikungunya Vaccine" appeared first on Outbreak News Today.